Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872311 · ClinicalTrials.gov registry record · NA
Open-Label Influenza Vaccine Evaluation
A NA study of Immune Response, sponsored by Marshfield Clinic Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
- 1
- Study location
NCT02872311: Completed NA study of Immune Response, sponsored by Marshfield Clinic Research Foundation.
NCT02872311 is a NA study of Immune Response that has completed, run by Marshfield Clinic Research Foundation. The registered enrollment target is 179 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02872311, a NA study of Immune Response, has completed, sponsored by Marshfield Clinic Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, randomized trial in up to 210 adults aged 65-74 years to evaluate the immune response to consecutive influenza vaccination across 2 seasons. Participants will be randomized to receive 1 of 3 licensed and recommended vaccines in the first year; 2 arms will receive the same vaccination in the second year and the third arm will be randomized again to 1 of 3 licensed vaccines. All participants will have pre and post-vaccination serum blood draws for a total of 6 draws over 18 months.
Primary Outcome
Hemagglutination Inhibition (HI) titers to vaccine viruses for high dose and adjuvanted vaccine recipients at 28 days post vaccination 2016-17
Conditions Studied
Interventions
- BIOLOGICAL High Dose Influenza vaccine
- BIOLOGICAL Adjuvanted Influenza vaccine
- BIOLOGICAL Standard Dose Influenza vaccine
- BIOLOGICAL Recombinant Influenza vaccine
Study Locations (1)
Wisconsin
- Marshfield Clinic - Marshfield Center - Marshfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-09 |
| Phase | NA |
What the finished NCT02872311 record still lists
NCT02872311 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Immune Response appearing as the primary indexed condition, and to 4 interventions - of which High Dose Influenza vaccine is the first listed.
NCT02872311 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT02872311 about?
NCT02872311 is a clinical study titled "Open-Label Influenza Vaccine Evaluation". This is an open-label, randomized trial in up to 210 adults aged 65-74 years to evaluate the immune response to consecutive influenza vaccination across 2 seasons. Participants will be randomized to receive 1 of 3 licensed and recommended vaccines in the first year; 2 arms will receive the same vacc...
What is the current status of trial NCT02872311?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2016-09. Estimated completion is 2018-09.
What conditions does trial NCT02872311 study?
This clinical trial studies the following conditions: Immune Response.
What interventions are being tested in trial NCT02872311?
The interventions under investigation include: High Dose Influenza vaccine (BIOLOGICAL), Adjuvanted Influenza vaccine (BIOLOGICAL), Standard Dose Influenza vaccine (BIOLOGICAL), Recombinant Influenza vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT02872311?
This trial is sponsored by Marshfield Clinic Research Foundation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02872311 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immune Response
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02872311's enrollment target sits among peer trials
179 604th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia